GLOBUS MEDICAL INCGMED決算レポート
NYSE · health technology
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
主要株主
| 株主 | 保有比率 | 株数 | 変動 | 基準日 |
|---|---|---|---|---|
| of Above Person | 15.76% | 21.3M | — | 2024-02-14 |
| The Vanguard Group | 9.54% | 11.3M | ▼ -4.92pp | 2024-02-13 |
| BlackRock, Inc. | 9.40% | 10.8M | ▼ -2.70pp | 2024-01-24 |
| S.S. OR | 5.20% | 7.0M | ▼ -0.50pp | 2024-11-14 |
| S OR | 0.00% | 379.6M | — | 2024-02-13 |
インサイダー取引
Net 90d: −$2.77M · buys $0 / sells $2.77M期間:
種別:
役職:
| インサイダー | 役職 | 種別 | ||||
|---|---|---|---|---|---|---|
| 2026-02-25 | Kelly Huller | EVP, GC, Corporate Secretary | Option exercise | 20.0K | $43.58 | $871.6K |
| 2026-02-25 | Kelly Huller | EVP, GC, Corporate Secretary | Sell (open market) | 20.0K | $94.50 | $1.89M |
| 2026-02-12 | Kelly Huller | EVP, GC, Corporate Secretary | Option exercise | 10.0K | $45.64 | $456.4K |
| 2026-02-12 | Kelly Huller | EVP, GC, Corporate Secretary | Sell (open market) | 10.0K | $87.67 | $876.7K |
1–4 of 4